Table 1.
Generic PROs | Disease-specific PROs | |
---|---|---|
Purpose | Intended for use in all individuals Overall impact of disease |
Evaluation of symptoms, functioning and perceptions that relate to a well-defined disease or condition |
Population | General population (healthy and non-healthy) Applicable across individuals with different diseases |
Used for patients with a specific disease or condition |
Strengths | Possible to compare QoL across populations or patient groups Enable comparisons between the relative burdens of diseases and their treatment benefits |
Often more sensitive to differences among clinically relevant groups and more responsive to small changes in health Provide insights into the relationships between pathophysiology and QoL impairments |
Limitations | Ceiling and floor effects are often more pronounced | Not possible to compare QoL across different groups of patients |
Examples | SF-36v2 Health survey, EQ-5D | ThyPRO, GO-QOL |
In this paper, we focus on PROs developed for benign thyroid diseases. EQ-5D, EuroQol Group EQ-5D Health Survey (19); GO-QOL, Graves’ Ophthalmopathy Quality Of Life survey (20); PROs, patient-reported outcomes; QoL, quality of life; SF-36v2, The 36-item Short-Form Health Survey version 2 (21); ThyPRO, Thyroid-Related Patient-Reported Outcome (22).
Factors to consider when choosing between generic and disease-specific PROs are shown in the table.